ImmuCell 股票

ImmuCell Corp. is a company based in Portland, Maine that is focused on the development, acquisition, manufacture, and sale of products for improving the health and productivity of dairy and beef cattle. With 67 full-time employees, the firm offers a range of products that aim to prevent scours in newborn dairy and beef calves, such as its First Defense product line.

The company has expanded its First Defense product line into five different products, with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus, and rotavirus pathogens. Its Tri-Shield First Defense product line extension is a calf-level, passive antibody product that provides immediate immunity against E. coli, coronavirus, and rotavirus.

ImmuCell Corp. is also engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The company’s products are designed to reduce the use of traditional antibiotics in food-producing animals.

As with any investment opportunity, it is important to conduct thorough research and analysis before investing in a stock. Keeping up to date with the latest developments in the industry and the company’s performance can help investors make informed decisions. For example, staying informed about the stock price today, premarket trends, and stocks share price today can help investors understand the company’s market position and make more informed investment decisions. However, it is important to remember that investing in the stock market carries risks and it is essential to make investment decisions based on your personal financial situation and investment goals.